Revenio Group
Revenio Group Oyj is a Finnish medical technology company specializing in ophthalmic diagnostic solutions and clinical imaging devices. The company designs, manufactures, and markets tonometers, retinal imaging devices, and visual field analyzers under the iCare brand name. Revenue is principally generated through equipment sales, disposable tonometer probes, software subscriptions, and maintenance servicing. Core end markets encompass ophthalmologists, optometrists, opticians, hospitals, and clinical health networks worldwide. Revenio Group holds the leading global market position in rebound tonometer technology for intraocular pressure measurement. The company is headquartered in Vantaa, Finland, and its shares trade on the Nasdaq Helsinki stock exchange.
15 of the funds FundTelligence covers report a position in Revenio Group.
- Legal name
- Revenio Group Oyj
- Sector
- Health Care
- Country
- Finland
- Funds holding it
- 15
- Exposure themes
- Ageing & Longevity, Healthy Ageing & Function, Vision
Funds holding Revenio Group
- Case Gaia Microcap — Case · 2.02 % (full portfolio disclosed, June 2026)
- Schroder ISF Nordic Smaller Companies — Schroders · 1.8 % (full portfolio disclosed, June 2026)
- Schroder ISF Nordic Micro Cap — Schroders · 1.61 % (full portfolio disclosed, June 2026)
- Case All Star Småbolag — Case · 1.48 % (full portfolio disclosed, June 2026)
- Protean Aktiesparfond Norden — Protean · 1.12 % (full portfolio disclosed, June 2026)
- Danske Invest Norden Ansvarlig Fokus — Danske Invest · 0.31 % (full portfolio disclosed, September 2026)
- Handelsbanken Norden Index Criteria — Handelsbanken · 0.15 % (full portfolio disclosed, October 2026)
- Nordea Premium Asset Management Growth — Nordea Funds · 0.02 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 15 funds holding it.